Compare Nu Holdings Ltd (NU) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nu Holdings Ltd vs uniQure N.V. Ordinary Shares — how do they compare? Nu Holdings Ltd trades at $14.55 (market cap $75.26B), while uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.48B). The key difference: Nu Holdings Ltd is far larger — about 50.9× uniQure N.V. Ordinary Shares's market cap, and Nu Holdings Ltd is trading nearer its 52-week high, uniQure N.V. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nu Holdings Ltd for 53 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| NU | QURE | |
|---|---|---|
Market Cap | $75.26B | $1.48B |
Volume | 60,119,584 | 2,488,780 |
Sector | Financials | Health |
52-Week High | $18.76 | $70.59 |
52-Week Low | $11.60 | $9.03 |
Typical Hold Time | 53 Days | 0 Days |
Enterprise Value | $97.88B | $728.62M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NU Holdings (NU) trades at $15.58, down 2.69% on the day, as the stock consolidates near key technical levels. The company demonstrates strong fundamental momentum with revenue growing from $3.0B in 2022 to $10.6B in 2025 and net income turning positive to $2.9B. Recent news highlights acquisition speculation regarding Monzo, though the company has denied pursuing a transaction. Technical indicators show a bullish moving average signal but neutral oscillators, with RSI suggesting potential overbought conditions.
The outlook remains positive given NU's expanding customer base and profitability trajectory, with analyst consensus favoring Buy ratings (56.5%) and a $16.53 price target representing 6% upside. Key risks include credit quality concerns from rising delinquencies and the stock's premium valuation multiples. The company's operational efficiency and Latin American expansion provide growth catalysts, though investors should monitor execution against earnings expectations.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nu Holdings Ltd
Nu Holdings Ltd is engaged in providing digital banking services. It offers several financial services such as Credit cards, Personal Account, Investments, Personal Loans, Insurance, Mobile payments, Business Account, and Rewards.
Read more on NU →About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →
